S.Biomedics is developing TED-A9, a Parkinson's disease treatment utilizing embryonic stem cells. Since 2023, it has been conducting clinical trials of phases 1 and 2a for 12 domestic Parkinson's ...

Afshar expects the demand for the Mytos platform to grow in the coming months, particularly from companies manufacturing stem cell therapies for neurodegenerative diseases like Parkinson’s ...

DIABETES, Parkinson's disease, degenerative disc disease, macular degeneration, stroke — what do these have in common? Besides being relatively debilitating conditions, all of these have been treated ...

aNSC: Adult neural stem cell; BM: Bone marrow; ESC: Embryonic stem cell ... can improve motor symptoms in animal models and Parkinson's disease (PD) patients. Open-label clinical studies using ...

which indicates that MSCs might be a new strategy for the treatment of immune-mediated diseases. Mesenchymal stem cells (MSCs) are a heterogeneous subset of stromal stem cells that can be isolated ...

Advanced 'Parkinson's in a Dish' Model Accelerates Brain Disease Research July 29, 2024 — Researchers have developed a model that rapidly converts stem cells to brain cells with protein ...

Bayer subsidiary BlueRock Therapeutics has dosed the first Parkinson's ... disease progresses. In the BlueRock trial, an unnamed patient has now been administered the first dose of pluripotent ...

Many degenerative diseases, like Parkinson’s disease, multiple sclerosis, or heart failure, have always been concerning when it comes to ...

Jan. 28, 2025 — A new study shows that asymptomatic brain metastasis is more common in stage 4 breast cancer patients than previously believed. The study suggests that doctors may need to ...